Arialys Therapeutics

Home Team News Careers Contact

News

« Back to News

December 11, 2024

In Vivo Podcast: Treating Autoimmune Neuropsychiatric Diseases

In this episode of the In Vivo podcast, Peter Flynn, CEO of Arialys Therapeutics, discusses the exciting field of autoimmune neuropsychiatry and the company’s monoclonal antibody, which it is investigating for the treatment of a rare condition called anti-NMDA receptor encephalitis and potentially other indications.

Read more and listen here.

Sign up for news updates

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Follow us

©2024 Arialys Therapeutics, 11099 North Torrey Pines Rd., Ste 290, La Jolla, CA 92037